Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma

Clinical trial NCT07084662 · RECRUITING

Trial details

NCT number: NCT07084662
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma (DLBCL)

Start date: 2025-09-11
Primary completion: 2028-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.